Innate Pharma raises euro 20 million in its second round of financing | Innate Pharma

Mon, 07/08/2002 - 17:23

PR in english	101.72 KB

Company
Science
Products
- Pipeline overview
- ------------------
- Lacutamab
- IPH4502
- Monalizumab
- Other Clinical Stage Assets
  - IPH6501
  - IPH6101
  - IPH6401
  - IPH5201
  - IPH5301
Partnering
Investors
Media
Careers